Biohaven Pharmaceutical Holding Company Ltd. BHVN
$ 45.32
0.29%
Quarterly report 2022-Q2
added 12-16-2023
Biohaven Pharmaceutical Holding Company Ltd. ROE Ratio 2011-2024 | BHVN
Annual ROE Ratio Biohaven Pharmaceutical Holding Company Ltd.
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
114.5 | 196.43 | 7122.91 | -159.64 | -96.38 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
7122.91 | -159.64 | 1435.57 |
Quarterly ROE Ratio Biohaven Pharmaceutical Holding Company Ltd.
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
135.41 | 109.46 | 138.68 | 129.75 | 170.86 | 226.63 | 288.7 | 752.61 | 701.53 | 2656.31 | 3995.07 | 6327.99 | 7122.91 | 5076.07 | 3605.31 | 736.22 | -159.64 | -143.88 | -130.64 | -124.56 | -25.43 | 51.64 | 141.87 | 176.95 | 141.01 | 84.45 | 21.7 | 6.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
7122.91 | -159.64 | 1150.48 |